Attorney General Kris Mayes today joined a coalition of 20 attorneys general in issuing a joint statement addressing concerns over a U.S. Food and Drug Administration (FDA) review of mifepristone. This review was referenced by Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Makary in response to a letter from Republican state attorneys general to the FDA calling for restrictions on or withdrawal of mifepristone from the market:  

“For more than 25 years, mifepristone has been used safely and effectively in the United States and globally. It is currently the most common method for early-term abortion care in the United States and is the standard of care for managing early miscarriage. The decision to reexamine access to this medication was made in response to a scientifically baseless letter and ignores decades of research that proves mifepristone is safe and effective. Medical decisions should be left between patients, their families, and their providers – and they should be guided by science, not political agendas. As state attorneys general, we have a responsibility to enforce state laws and protect our residents, including their access to reproductive care. If access to mifepristone is challenged, we will take action to protect it.”